Cargando…
CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
Expression of alternatively spliced CD44 isoforms has been reported to correlate with poor prognosis in human squamous cell cancers, i.e. squamous cell cancer of the lung and cervix. The aim of this study was to evaluate whether CD44 isoform expression is a prognostic factor in early-stage squamous...
Autores principales: | Tempfer, C., Sliutz, G., Haeusler, G., Speiser, P., Reinthaller, A., Breitenecker, G., Vavra, N., Kainz, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063157/ https://www.ncbi.nlm.nih.gov/pubmed/9792156 |
Ejemplares similares
-
The prognostic value of CD44 isoform expression in endometrial cancer.
por: Tempfer, C., et al.
Publicado: (1998) -
Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
por: Sliutz, G., et al.
Publicado: (1995) -
Serum M3/M21 in ovarian cancer patients.
por: Tempfer, C., et al.
Publicado: (1997) -
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999) -
Menstrual phase and timing of breast cancer surgery: statistical aspects.
por: Haeusler, G., et al.
Publicado: (1996)